The PamChip ® assay not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage.
The vasculature is crucial for tumor development, progression, and metastatic potential. Combined modality therapy using anti-angiogenic agents with radiation can potentially have a large anti-carcinogenic treatment. Antivascular treatment may either cause hypoxia and thereby increase resistance or improve blood flow within tumors which then allows chemotherapeutics to better permeate a tumor as well as improving oxygenation for radiation sensitization. However, vascular destruction could also improve tumor control by simpl y eliminating the nutrients necessary for tumor preservation.
49 specific tyrosine phosphopeptides were found to be differentially affected by irradiation over the investigated time course. The Tropomyosin receptor kinase (Trk) family members,TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. Targeting TrkA and TrkB with small molecule inhibitors, HUVEC cells were protected from radiation damage. Stimulation of TrkA using gambogic amide promoted radiation enhancement to repeat the finding of the increased TRK phosphorylation, HUVEC cells were subjected to sham (0 Gy) or 3 Gy irradiation followed by immuno precipitation of Trk using a pan-Trk antibody. These lysates were then analyzed by western blot and it was shown that Trk phosphorylation is induced by 3 Gy irradiation.
"As an alternative, we utilized a platform that measures phosphorylation events within a whole cell lysate kinase assay" "Author Quote"
Study Design
Kinomic profiling approach identifies Trk as a novel radiation Modulator.
HUVEC cells (human umbilical vein endothelial cells) as a model for vasculature, were irradiated with 3 GY and whole cell lysates were prepared 0, 2, 5, 15, 30, or 60 min postirradiation in four technical and two separate biological replicates. These lysates were analyzed on the tyrosine kinase PamChip ® array (PTK) to investigate the mechanism of radiation response.
Key Findings
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John S. Jarboe et al, Radiotherapy and Oncology, Volume 103, Pages 380-387, 2012 Figure 2 Radiation-induced Trk activation and impact of Trk inhibition on radiation response. (A) Peptide set 2 is shown with normalized intensity (log scale) of phosphorylation of individual peptides after 0 (GY0-1 and -2) or 3 Gy (GY3-1 and -2) represented by a blue line at each time point (vertical lines). Highlighted in red is a single peptide of set 2 representing the phospho-site of NTRK1, also known as TrkA, which is shown separately in (B) with standard error shown. (C) A pan-Trk antibody was used to immunoprecipitate (IP) Trk in irradiated (3 Gy) and sham treated (0 Gy) HUVEC which were then subjected to SDS-PAGE and immunoblotting (IB) for phosphotyrosine (PY20). 
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